Home | Coverage | Agents | Pulse | LogIn |
Darwin Score | -37 |
Ticker | SAR |
Latest Price | 0.21 GBP as of close on 04-Jul-2025 |
3 Month price range | 0.14 to 0.21 GBP |
Market Capitalisation | 26.55Mn GBP |
Country | United Great Britain and Northern Ireland |
Region | Europe |
Economic Sector | Health Care |
Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
Industry | Pharmaceuticals |
Sub-Industry | Pharmaceuticals |
Description | Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also involves in developing SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Checkpoint kinase 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. Sareum Holdings plc was formerly known as Keepfast plc and changed its name to Sareum Holdings plc in July 2004. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom. See More ... |
Company URL | https://www.sareum.com |
See Darwins Full Analysis for Sareum Holdings PLC |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Sareum Holdings PLC. Further information and full detail is available when you login.
TMA Part | Focus of Analysis | TMA Score |
---|---|---|
Price | Analysis of performance, trend, RSI, OBV and moving averages | -8 |
Sentiment | News and Candle Patterns. | 0 |
Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -6 |
Flow | Institutional, Fund and Insider buying and selling. | 0 |
Models | Forecast models. | -23 |
There are 4 live alerts for Sareum Holdings PLC.
There are 4 peers of Sareum Holdings PLC.
Asset Name | Industry Group | Perf(20d)% | Asset Score |
---|---|---|---|
AstraZeneca PLC (AZN) | Pharmaceuticals | -4.6 | -2 |
GSK plc (GSK) | Pharmaceuticals | -7.8 | +6 |
Hikma Pharmaceuticals PLC (HIK) | Pharmaceuticals | -5.6 | 0 |
Indivior PLC (INDV) | Pharmaceuticals | +14.3 | +35 |
To see complete information on Sareum Holdings PLC or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
©2025 Darwin Knows - All Rights Reserved |